Razmkon A, Abdollahifard S, Rezaei H, Bahadori A R, Eskandarzadeh P, Rastegar Kazerooni A. Effect of Deep Brain Stimulation on Parkinson Disease Dementia: A Systematic Review and Meta-analysis. BCN 2024; 15 (2) :157-164
URL:
http://bcn.iums.ac.ir/article-1-2177-en.html
1- Research Center for Neuromodulation and Pain, Shiraz University of Medical Sciences, Shiraz, Iran.
Abstract:
Introduction: Patients in the early stages of Parkinson disease (PD) may have subtle cognitive deficits, while overt cognitive deficits are usually manifestations of late-stage PD. There is still a debate on the outcome of deep brain stimulation (DBS) on the cognitive function of PD patients. This study aimed to investigate the effect of subthalamic nucleus (STN)-DBS on the dementia of PD patients after surgery compared to medical therapy and other procedures.
Methods: We searched PubMed, Scopus, Cochrane Library, and Web of Science database on October 2020, with keywords: “Deep brain stimulation,” “Parkinson disease,” “dementia,” and “memory.” Reviews, abstracts, case presentations, and letters were excluded.
Results: In total, 491 studies were screened after removing the duplicates. The screening results yielded 81 articles to be screened for eligibility. Finally, 6 studies were included in this meta-analysis for synthesis. Overall, 800 patients were included in this meta-analysis, using the Mattis dementia rating scale (MDRS) and descriptive data from the articles extracted to assess global dementia.
Conclusion: Our results suggest that the STN-DBS group showed a larger cognitive decline than the patients receiving the best medical treatment (BMT). However, comparing STN-DBS with globus pallidus interna stimulation and pallidotomy could not demonstrate a significant statistical effect on the global dementia of patients. More long-term studies with larger sample sizes are needed to validate current findings.
Full-Text [PDF 600 kb]
| |
Full-Text (HTML)
• STN-DBS can cause higher cognitive decline in PD patients compared to the medical therapy.
• There is no significant difference in the effect of STN-DBS compared to globus pallidus interna stimulation and pallidotomy methods in PD patients.
Plain Language Summary
Patients with Parkinson’s disease (PD) may experience some types of cognitive deficits in the course of their disease. This cognitive decline is called Parkinson’s disease dementia or PDD. As the PD advances, patients may not respond to conventional treatment such as medical therapy. In such cases, deep brain stimulation (DBS) may be offered to these patients to improve their symptoms but the actual effect of DBS on these patients is controversial in the literature. Hence, we have conducted this systematic review and meta-analysis to investigate the effect of DBS targeting the subthalamic nucleus (STN), which is the main target for patients with PD, on the PDD, and compare STN-DBS with other targets. Our results suggest that patients with STN-DBS may experience a larger cognitive decline than patients receiving the best medical treatment (BMT). However, no significant difference was found between STN-DBS and other targets.
Type of Study:
Review |
Subject:
Clinical Neuroscience Received: 2021/05/24 | Accepted: 2022/09/27 | Published: 2024/03/1